Elena Klenova

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Surgery as local consolidation therapy before progression in oncogene-driven stage IV NSCLC: a patient and advocacy perspective.

Surgery as local consolidation therapy before progression in oncogene-driven stage IV NSCLC: a patient and advocacy perspective.

Journal: BMJ oncology

Published: September 04, 2025

Molecular Mechanisms and Treatment Strategies of ALK-Positive Lung Cancer: A Beginner's Guide for Patients, Their Families and Carers.

Molecular Mechanisms and Treatment Strategies of ALK-Positive Lung Cancer: A Beginner's Guide for Patients, Their Families and Carers.

Journal: Thoracic cancer

Published: August 06, 2025

Intracellular and extracellular activities of V-domain Ig-containing suppressor of T cell activation (VISTA) modulated by immunosuppressive factors of tumour microenvironment.

Intracellular and extracellular activities of V-domain Ig-containing suppressor of T cell activation (VISTA) modulated by immunosuppressive factors of tumour microenvironment.

Journal: Cancer letters

Published: December 26, 2024

Nucleosome reorganisation in breast cancer tissues.

Nucleosome reorganisation in breast cancer tissues.

Journal: Clinical epigenetics

Published: December 29, 2023

L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytes.

L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytes.

Journal: Oncoimmunology

Published: August 14, 2023

High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells.

High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells.

Journal: Frontiers in immunology

Published: March 03, 2021

Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells.

Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells.

Journal: Aging

Published: September 23, 2020

The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer.

The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer.

Journal: Frontiers in immunology

Published: May 02, 2019

Poly(ADP-ribosyl)ation associated changes in CTCF-chromatin binding and gene expression in breast cells.

Poly(ADP-ribosyl)ation associated changes in CTCF-chromatin binding and gene expression in breast cells.

Journal: Biochimica et biophysica acta. Gene regulatory mechanisms

Published: January 23, 2018

Role of CTCF poly(ADP-Ribosyl)ation in the regulation of apoptosis in breast cancer cells.

Role of CTCF poly(ADP-Ribosyl)ation in the regulation of apoptosis in breast cancer cells.

Journal: Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology

Published: March 27, 2015

Expression of the cancer-testis antigen BORIS correlates with prostate cancer.

Expression of the cancer-testis antigen BORIS correlates with prostate cancer.

Journal: The Prostate

Published: August 06, 2013

A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells.

A novel mechanism for CTCF in the epigenetic regulation of Bax in breast cancer cells.

Journal: Neoplasia (New York, N.Y.)

Published: November 21, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026